Identification of Seebri Breezhaler:

No description

Search images on Google      Product Monograph

Active Ingredients:

• glycopyrronium (glycopyrronium bromide), 50 MCG

DIN: 02394936

Dosage Form(s): CAPSULE

Route(s) of Administration: INHALATION

Description: CAPSULES TO BE USED ONLY WITH SEEBRI BREEZHALER INHALATION DEVICE - ORAL INHALATION

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC  –  official site

ATC:

• R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
• R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS (ATC, WHO)
• R03BB - Anticholinergics (ATC, WHO)
• R03BB06 - GLYCOPYRRONIUM BROMIDE (WHO)

Reference brand drug: Seebri

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 30

 

External Links for Seebri Breezhaler:

Search on Google

• Seebri Breezhaler side effects
• Seebri Breezhaler dosage
• glycopyrronium side effects
• glycopyrronium dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find seebri breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.